Prosecution Insights
Last updated: October 27, 2026

University of Washington

Technology area: Biotechnology & Pharmaceuticals

72 pending office actions • 50 art units • 64 examiners • 0 of 72 (0%) have an AI response strategy ready • 69 patents granted in the last 365 days

Analysis

University of Washington has 77 pending office actions in Biotechnology & Pharmaceuticals. The docket spans 69 distinct examiners and 55 distinct art units, reflecting broad examination coverage with repeated assignments across both dimensions. This distribution creates a substantial coordination requirement for deadlines, technical positions, and response quality.

MUMMERT, STEPHANIE KANE is the busiest examiner, with 5 pending matters. That examiner provides a useful focal point for reviewing related records, but the broader docket remains widely distributed. Counsel should combine examiner-specific review with art-unit tracking and portfolio-wide oversight of recurring claim and disclosure issues.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

72
Total Pending OAs
44
Non-Final OAs
24
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 19 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

12
Overdue
0
Due this week
5
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 19 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (12)Due ≤ 30 days (5)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

44
Hard (61%)
22
Medium (31%)
6
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (3%)
§101 + other16 (22%)
§103 only16 (22%)
§102 only1 (1%)
§112 only6 (8%)
Double-patenting + other5 (7%)
Multi-statute (no §101)26 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

55
Life Sciences
76% of docket
2
Information Tech
3% of docket
2
Communications
3% of docket
2
Semiconductors
3% of docket
6
Mechanical / Eng
8% of docket
5
Business / Other
7% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

720 h
Manual time on pending OAs
144 h
Time saved (low, 20%)
252 h
Time saved (mid, 35%)
6.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MUMMERT, STEPHANIE KANE 5 61.4% +21.2%
HAVLIN, ROBERT H 2 51.3% +28.3%
PHAM, KHAI QUYNH TIEN 2 0.0% +0.0%
GREENE, CAROLYN LEE 2 65.7% +46.1%
BUNKER, AMY M 2 29.1% +45.6%
FARAG, AMAL ALY 1 68.0% +38.4%
TISSIRE, ABDELAAZIZ 1 84.1% +13.8%
MENDOZA, WILSON GALLARDO 1 100.0% +0.0%
LIN, ERICA S Y 1 86.0% +2.7%
BANERJEE, KOYELI 1 33.3% +0.0%

Hard Cases (46)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17730130 REAGENTS AND METHODS FOR LABELING MOLECULES WITH ASTATINE ISOTOPES IN HIGHER OXIDATION STATES JONES, DAMERON LEVEST 124d overdue
17916683 METHODS TO ENRICH ENTEROENDOCRINE CELLS AND THEIR SUBTYPES IN THE CONTIGUOUS, INTESTINAL MONOLAYER SYSTEMS ROGERS, ERIC JASON 38d overdue
17999011 PREDICTING INCIPIENT SEPARATION IN TURBULENT FLOWS HANN, JAY B 31d overdue
18223989 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME BOWERS, ERIN M 16d overdue
16625100 HIGH-THROUGHPUT SINGLE-CELL TRANSCRIPTOME LIBRARIES AND METHODS OF MAKING AND OF USING BUNKER, AMY M 16d overdue
18120319 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME DAVIS, RUTH A 13d
18344689 MODULAR EXPANSION JOINTS CONFIGURED TO MINIMIZE NOISE, BRIDGES INCLUDING THE SAME, AND METHODS OF MAKING AND USING THE SAME HARTMANN, GARY S 21d
17760180 POLYPEPTIDES AND THEIR USE BLUMEL, BENJAMIN P 21d

Interview Candidates (13)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18455152 METHODS AND KITS FOR LABELING CELLULAR MOLECULES HAVLIN, ROBERT H 66d overdue
16625100 HIGH-THROUGHPUT SINGLE-CELL TRANSCRIPTOME LIBRARIES AND METHODS OF MAKING AND OF USING BUNKER, AMY M 16d overdue
19136218 AXIALLY STEERED BOILING HISTOTRIPSY FARAG, AMAL ALY —
19216139 METHODS AND KITS FOR LABELING CELLULAR MOLECULES HAVLIN, ROBERT H —
18935984 THIN ON-SENSOR NANOPHOTONIC ARRAY CAMERAS TISSIRE, ABDELAAZIZ —
18649007 METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT WITH APPLICATIONS TO ERROR CORRECTED NUCLEIC ACID SEQUENCING GREENE, CAROLYN LEE —
18292665 MULTIPLEXED IN SITU SIGNAL AMPLIFICATION WITH SPLINT LIGATION EXTENSION (SLX) PROBES GREENE, CAROLYN LEE —
18651577 METHODS OF LOWERING THE ERROR RATE OF MASSIVELY PARALLEL DNA SEQUENCING USING DUPLEX CONSENSUS SEQUENCING MUMMERT, STEPHANIE KANE —

Top Art Units

Art UnitApps
1684 4
1626 3
1658 3
1652 3
1653 3
3798 2
1681 2
1635 2
1683 2
1675 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19136218 AXIALLY STEERED BOILING HISTOTRIPSY FARAG, AMAL ALY 3798 §103 Non-Final OA — Pending Jun 05, 2025
19216139 METHODS AND KITS FOR LABELING CELLULAR MOLECULES HAVLIN, ROBERT H 1626 §102§103§112DP Non-Final OA — Pending May 22, 2025
18935984 THIN ON-SENSOR NANOPHOTONIC ARRAY CAMERAS TISSIRE, ABDELAAZIZ 2638 §102§103 Non-Final OA — Pending Nov 04, 2024
18843117 SIZE-EXCLUSION MEMBRANE FOR SELECTIVE UREA REMOVAL ON KIDNEY DIALYSIS MACHINE MENDOZA, WILSON GALLARDO 1772 §102§103 Non-Final OA — Pending Aug 30, 2024
18817368 Highly Flexible Thermoelectric Composite Materials for Temperature Sensing in Aircraft LIN, ERICA S Y 2853 §102§103§112 Non-Final OA — Pending Aug 28, 2024
18814954 Reagents and methods for treating bacterial infection BANERJEE, KOYELI 1658 §101§102§103§112DP Non-Final OA — Pending Aug 26, 2024
18799107 De novo designed sequence-specific DNA binding proteins KONOPELSKI SNAVEL, SARA ELIZABETH 1658 §101§102§112 Non-Final OA — Pending Aug 09, 2024
18788492 HYBRID SPATIAL LIGHT MODULATOR KAULFUSS, PETER LLOYD 2874 §102§103§112 Non-Final OA — Pending Jul 30, 2024
18725318 Microbial-Embedded Hydrogel Beads and Methods of Use DURYEE, ALEXANDER MARSH 1657 §101§103§112 Non-Final OA — Pending Jun 28, 2024
18723132 IRON OXIDE NANOPARTICLE-MEDIATED RADIATION DELIVERY FOR TARGETED CANCER TREATMENT HOERNER, PAUL ELLSWORTH 1611 §103 Non-Final OA — Pending Jun 21, 2024
18654545 HIGH-THROUGHPUT SINGLE-CELL SEQUENCING WITH REDUCED AMPLIFICATION BIAS PHAM, KHAI QUYNH TIEN 1684 §102§103§112Other Non-Final OA — Pending May 03, 2024
18649007 METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT WITH APPLICATIONS TO ERROR CORRECTED NUCLEIC ACID SEQUENCING GREENE, CAROLYN LEE 1681 §112DP Non-Final OA — Pending Apr 29, 2024
18638492 COMMUNICATION USING MODULATED THERMAL NOISE RACHEDINE, MOHAMMED 2646 §103 Non-Final OA — Pending Apr 17, 2024
18698565 NECK MASSAGING SYSTEMS AND METHODS OF USING THE SAME DAHER, KIRA B 3785 §102§103§112 Non-Final OA — Pending Apr 04, 2024
18607269 METHODS OF TREATING PANCREATIC CANCER MYERS, CARLA J 1682 §101§103§112 Non-Final OA — Pending Mar 15, 2024
18582346 COMPOSITIONS AND METHODS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY BIOMARKER DETECTION CHHAY, BONIRATH 1645 §101§112 Non-Final OA — Pending Feb 20, 2024
18438692 TRANSRECTAL ULTRASOUND PROBE FOR BOILING HISTOTRIPSY ABLATION OF PROSTATE, AND ASSOCIATED SYSTEMS AND METHODS DAVIS, AMELIE R 3798 §103 Final Rejection 3d overdue Pending Feb 12, 2024
18293011 TEMPERATURE CONTROLLED BIOLOGICAL GROWTH SURFACES FOR HIGHER MICROBIAL ACTIVITY IN BIOPROCESSING HOBBS, MICHAEL L 1799 §102§103 Final Rejection — Pending Jan 29, 2024
18292665 MULTIPLEXED IN SITU SIGNAL AMPLIFICATION WITH SPLINT LIGATION EXTENSION (SLX) PROBES GREENE, CAROLYN LEE 1681 §103§112 Non-Final OA — Pending Jan 26, 2024
18291018 GENERATION OF LARGE PROTEINS BY CO-DELIVERY OF MULTIPLE VECTORS BRETZ, COREY LANE 1635 §103§112 Non-Final OA — Pending Jan 22, 2024
18578523 EFFICIENT DUPLEX SEQUENCING USING HIGH FIDELITY NEXT GENERATION SEQUENCING READS SCHLOOP, ALLISON ELIZABETH 1683 §103§112 Non-Final OA — Pending Jan 11, 2024
18410822 METHODS AND COMPOSITIONS TO DIAGNOSE AND TREAT TAUOPATHIES UTILIZING TRANSCRIPT VARIANTS OF PSEN2 SAPKOTA, SURAJ 1635 §102§112 Non-Final OA — Pending Jan 11, 2024
18577620 ENZYME-LOADED POLYMERIC NANOPARTICLES AND METHODS OF MANUFACTURE AND USE OF SAME SHELTON, SYNPHANE LA'SHAWN 1652 §103 Final Rejection — Pending Jan 08, 2024
18576518 MULTIPLE DE NOVO DESIGNED PROTEIN BINDING PROTEINS KATAKAM, SUDHAKAR 1658 §112 Non-Final OA — Pending Jan 04, 2024
18389890 IN SITU COMBINATORIAL LABELING OF CELLULAR MOLECULES GUSSOW, ANNE 1683 §112DP Non-Final OA — Pending Dec 20, 2023
18566519 BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS BARRON, SEAN C 1653 §102§103 Non-Final OA — Pending Dec 01, 2023
18558689 ELECTROPHYSIOLOGICAL MODIFICATION TO SUPPRESS ARRHYTHMIAS MACFARLANE, STACEY NEE 1675 §101§112 Non-Final OA — Pending Nov 02, 2023
18549077 PICOSCALE THIN LAYER CHROMATOGRAPHY FOR ANALYSIS OF SINGLE CELLS AND MICROSAMPLES WRIGHT, PATRICIA KATHRYN 1798 §102 Non-Final OA — Pending Sep 05, 2023
18547897 Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants YOON, CHANEL J 3791 §101§102§103§112Other Non-Final OA 27d Pending Aug 25, 2023
18455152 METHODS AND KITS FOR LABELING CELLULAR MOLECULES HAVLIN, ROBERT H 1626 §103 Final Rejection 66d overdue Pending Aug 24, 2023
18547644 COMPOSITIONS AND METHODS FOR STABILIZATION OF ALLOSTERIC PROTEINS AEDER, SEAN E 1642 §112 Non-Final OA 23d overdue Pending Aug 23, 2023
18547629 BACTERIAL DNA CYTOSINE DEAMINASES FOR MAPPING DNA METHYLATION SITES MOAZZAMI, NAGHMEH NINA 1652 §112 Final Rejection 5d overdue Pending Aug 23, 2023
18453178 BIOPLASTIC MATERIALS OBTAINED FROM BIOLOGICAL MATTER MCDONOUGH, JAMES E 1734 §102§103§112 Final Rejection — Pending Aug 21, 2023
18275985 REPROGRAMMABLE SYSTEMS AND METHODS FOR CONTROLLING THE SAME KHAN, IFTEKHAR A 2187 §103 Non-Final OA — Pending Aug 04, 2023
18223989 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME BOWERS, ERIN M 1653 §103§112 Final Rejection 16d overdue Pending Jul 19, 2023
18260305 MODULAR KINETICALLY-CONTROLLED FUNCTIONAL RNA CONSTRUCTS AND RELATED COMPOSITIONS, SYSTEMS, AND METHODS WEHBE, ANNE MARIE SABRINA 1634 §102§103§112 Non-Final OA — Pending Jul 03, 2023
18344689 MODULAR EXPANSION JOINTS CONFIGURED TO MINIMIZE NOISE, BRIDGES INCLUDING THE SAME, AND METHODS OF MAKING AND USING THE SAME HARTMANN, GARY S 3671 §102§103§112 Non-Final OA 21d Pending Jun 29, 2023
18258735 PHOTOPATTERNED BIOMOLECULE IMMOBILIZATION TO GUIDE 3D CELL FATE IN NATURAL PROTEIN-BASED HYDROGELS KUCKLA, ANNA GRACE 1626 §102§112 Non-Final OA — Pending Jun 21, 2023
18251514 PRECISE GENOME DELETION AND REPLACEMENT METHOD BASED ON PRIME EDITING TRAN, CHRISTINA L 1637 §102§103§112 Non-Final OA — Pending May 02, 2023
18034583 HYDROTHERMAL REACTOR SYSTEMS AND METHODS MCGANN, BERNADETTE KAREN 1773 §103 Final Rejection — Pending Apr 28, 2023
18306960 GENETIC MANIPULATION METHOD IN BACTERIA RAMIREZ, DELIA M 1652 §102§112 Non-Final OA — Pending Apr 25, 2023
18134993 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME LIU, SUE XU 1616 §101§112DP Non-Final OA — Pending Apr 14, 2023
18120319 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME DAVIS, RUTH A 1699 §101§102§103§112Other Non-Final OA 13d Pending Mar 10, 2023
18177022 BIORESORBABLE TUBULAR ORGAN STENT PELLEGRINO, BRIAN E 3799 §102§103 Non-Final OA — Pending Mar 01, 2023
18006413 IN VIVO SCREENING ARRAY TICHY, JENNIFER M.H. 1653 §103§112 Non-Final OA — Pending Jan 23, 2023
18011687 METHODS AND COMPOSITIONS FOR THE MOLECULAR DIAGNOSIS OF MICROSATELLITE INSTABILITY AND TREATMENTS FOR CANCER PULLIAM, JOSEPH CONSTANTINE 1687 §101§103 Final Rejection — Pending Dec 20, 2022
17999011 PREDICTING INCIPIENT SEPARATION IN TURBULENT FLOWS HANN, JAY B 2186 §101 Final Rejection 31d overdue Pending Nov 16, 2022
17998459 APPARATUS AND METHOD FOR MEASUREMENT OF HALOGENS IN SAMPLES SIMMONS, VALERIE MICHELLE 1758 §103 Final Rejection — Pending Nov 10, 2022
17995687 CONDITIONING REGIMENS FOR IN VIVO GENE THERAPY CONNORS, ALEXANDRA F 1634 §103 Non-Final OA 22d Pending Oct 06, 2022
17916683 METHODS TO ENRICH ENTEROENDOCRINE CELLS AND THEIR SUBTYPES IN THE CONTIGUOUS, INTESTINAL MONOLAYER SYSTEMS ROGERS, ERIC JASON 1638 §103§112 Non-Final OA 38d overdue Pending Oct 03, 2022

View all 72 →

Managing University of Washington's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does University of Washington have?

University of Washington has 72 pending office actions as of October 2026, spread across 50 art units and 64 examiners.

Which USPTO examiner handles the most University of Washington applications?

Stephanie Kane Mummert has the most, with 5 of University of Washington's pending office actions.

What technology area are University of Washington's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month